DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

Molecular imaging and targeted radiotherapy with radiolabeled cholecystokinin-2 receptor (CCK2R) targeting peptide probes holds high promise to improve the clinical management of patients with metastatic medullary thyroid carcinoma and other CCK2R-expressing malignancies. Low stability and suboptima...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Nucl Med
Glavni autori: Klingler, Maximilian, Summer, Dominik, Rangger, Christine, Haubner, Roland, Foster, Julie, Sosabowski, Jane, Decristoforo, Clemens, Virgolini, Irene, von Guggenberg, Elisabeth
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2019
Teme:
Radiochemistry
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6604694/
https://ncbi.nlm.nih.gov/pubmed/30530828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.221283
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items